An observational study found large methodological heterogeneity in systematic reviews addressing prevalence and cumulative incidence.

Incidence Meta-analysis Methodology Prevalence Research reporting Systematic review

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
03 2020
Historique:
received: 22 09 2019
revised: 09 11 2019
accepted: 02 12 2019
pubmed: 7 12 2019
medline: 2 10 2020
entrez: 7 12 2019
Statut: ppublish

Résumé

The objective of this study was to assess reporting and methodological aspects of systematic reviews (SRs) on prevalence and cumulative incidence data. We searched PubMed up to 18 April, 2018, and drew a random sample of eligible SRs. The included 215 SRs were reported in 187 different journals. 58.1% were published between 2015 and 2018. Few SRs were registered with PROSPERO (5.6%). One-quarter considered articles without languages restrictions (25.1%). Regional restrictions of included studies were applied in 22.8%. A meta-analysis was carried out in 40.5% of the SRs. One hundred and six studies (49.3%) assessed risk of bias or study quality. A total of 41 different existing tools as well as 15 tools developed by the authors themselves were used. The most commonly applied tools were the Newcastle-Ottawa Scale (15.1%), STROBE (13.5%), and the Cochrane Collaboration's tool for assessing risk of bias (7.9%). We found large heterogeneity in characteristics, reporting, and methodological aspects of SRs on prevalence and cumulative incidence data, especially when compared with other types of SRs. Newly developed or revised guidance on how to conduct and report SRs as well as instruments for critical appraisal should consider the diversity of review types.

Identifiants

pubmed: 31809847
pii: S0895-4356(19)30882-0
doi: 10.1016/j.jclinepi.2019.12.003
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-99

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Falk Hoffmann (F)

School of Medicine and Health Sciences, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany. Electronic address: falk.hoffmann@uni-oldenburg.de.

Daniela Eggers (D)

School of Medicine and Health Sciences, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany; Nursing Research Group, Institute of Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Dawid Pieper (D)

Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.

Hajo Zeeb (H)

Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany; Health Sciences Bremen, University of Bremen, Bremen, Germany.

Katharina Allers (K)

School of Medicine and Health Sciences, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH